This mini-review looked at how CAC scoring is used in clinical practice for coronary artery disease. The study examined whether using calcium scores changes how doctors estimate risk and manage patients compared to standard calculators. It also checked if treating based on calcium scores slows the growth of plaque in arteries.
Researchers found that CAC scoring is a robust and reproducible way to measure the total amount of atherosclerotic burden. A calcium score of zero was linked to lower near-term risk, while a score of 1,000 or higher identified a distinct group of patients at very high risk. Additionally, the review suggested that treatment guided by CAC scores might reduce plaque progression.
The authors noted that there were limitations regarding the use of CAC scoring itself. While the review includes a practical flowchart for selective use in prevention pathways, the evidence is not from large randomized trials. Readers should understand that this is early information and does not yet prove that CAC-guided treatment is superior to current standard care.
The main takeaway is that CAC scoring offers useful information for risk identification, but more research is needed to confirm its impact on long-term outcomes and safety before it changes standard practice widely.